A Soft Silicone Wound Contact Layer Containing Silver in the Treatment of Skin Grafts in Surgical Burn Patients.

Part A Inclusion Criteria * Subjects with burn injury resulting in up to 30% TBSA * Full thickness area of burn should not be more than 20% * Area in need of skin grafting can be 1-15% TBSA * Study site area must have healthy, intact peri-wound skin surrounding it to allow for adequate overlap of study product * Thermal injuries only * Subjects age 18 months to \< 65 years. * Signed informed consent * Subjects who are younger than the legal consenting age must in addition to their own assent form have a signature from a legally authorized representative. Exclusion Criteria * Greater than 30% TBSA * Full thickness areas greater than 20% TBSA * Full thickness area to be grafted less than 1% * Presence of respiratory involvement * Subjects on mechanical ventilation * Subjects with infected burn wounds * Subjects with organ failure * Diagnosed underlying disease(s) (e.g. HIV/AIDS, cancer and severe aeaemia) judged by the investigator to be a potential interference in the treatment * Subjects treated with systemic glucocorticosteroids, except patients taking occasional doses or doses less than 10mg prednisolone/day or equivalent * Known allergy/hypersensitivity to any of the components of the investigation products. * Subjects with physical and/or mental conditions that are not expected to comply with the investigation, including patients totally confined to bed * Participation in other clinical investigation(s) within 1 month prior to start of the investigation * Previous randomized to this investigation Part B Inclusion Criteria -There must be healthy, intact peri-wound skin surrounding the planned donor site to allow for adequate overlap of study product (5 cm) Exclusion Criteria * Investigator do not agree to treat the donor site with Mepilex Transfer Ag * The subject do not agree to participate in the donor site part